Impact of Helicobacter pylori Infection and Outcome of Anti-Helicobacter pylori Therapy in Patients with Reflux Laryngopharyngitis

Table 4

Therapeutic outcome in the Hp therapy and control groups.

Group	n	CR (n, %)	PR (n, %)	NR (n, %)	OR (n, %)	value^a
Control	145	35 (24.14)	73 (50.34)	37 (25.52)	108 (74.48)	<0.001
Hp therapy	145	69 (47.59)	62 (42.76)	14 (9.66)	131 (90.34)

CR = complete responses; Hp = Helicobacter pylori; NR = no response; OR = overall response; PR = partial response. value was determined for the difference in OR between the control and experimental groups.